U.S. flag

An official website of the United States government

NM_005876.5(SPEG):c.8872C>T (p.Arg2958Ter) AND Myopathy, centronuclear, 5

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 25, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002810024.2

Allele description [Variation Report for NM_005876.5(SPEG):c.8872C>T (p.Arg2958Ter)]

NM_005876.5(SPEG):c.8872C>T (p.Arg2958Ter)

Genes:
ASIC4-AS1:ASIC4 antisense RNA 1 [Gene - HGNC]
SPEG:striated muscle enriched protein kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_005876.5(SPEG):c.8872C>T (p.Arg2958Ter)
Other names:
NM_005876.5:c.8872C>T
HGVS:
  • NC_000002.12:g.219489890C>T
  • NG_051022.1:g.60676C>T
  • NM_005876.5:c.8872C>TMANE SELECT
  • NP_005867.3:p.Arg2958Ter
  • NC_000002.11:g.220354612C>T
Protein change:
R2958*
Links:
dbSNP: rs764429761
NCBI 1000 Genomes Browser:
rs764429761
Molecular consequence:
  • NM_005876.5:c.8872C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Myopathy, centronuclear, 5 (CNM5)
Identifiers:
MONDO: MONDO:0014418; MedGen: C4014814; Orphanet: 169186; OMIM: 615959

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003761226Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 25, 2023)
germlinecuration

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, SCV003761226.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (1)

Description

The homozygous p.Arg2958Ter variant in SPEG was identified by our study in one individual with congenital myopathy. The p.Arg2958Ter variant in SPEG has been reported in two siblings with congenital myopathy and segregated with disease in these two affected relatives from this one family (PMID: 34742623), but has been identified in 0.003% (1/29644) of South Asian chromosomes by the Genome Aggregation Consortium (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs764429761). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This nonsense variant leads to a premature termination codon at position 2958, which is predicted to lead to a truncated or absent protein. Loss of function of the SPEG gene is an established disease mechanism in autosomal recessive centronuclear myopathy 5. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive centronuclear myopathy 5. ACMG/AMP Criteria applied: PVS1, PM2_Supporting, PM3_Supporting (Richards 2015).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 16, 2025